![Michael Benkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Benkowitz
President at UNITED THERAPEUTICS CORPORATION
Net worth: 844 315 $ as of 2025-05-30
Profile
Michael Ian Benkowitz is on the board of United Therapeutics Europe Ltd. and President & Chief Operating Officer at United Therapeutics Corp.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-03-09 | 2,648 ( 0.01% ) | 844 315 $ | 2025-05-30 |
Latest news about Michael Benkowitz
Michael Benkowitz active positions
| Companies | Position | Start |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | President | 2016-06-25 |
| MIROMATRIX MEDICAL INC. | Chief Operating Officer | 2023-12-10 |
United Therapeutics Europe Ltd.
 United Therapeutics Europe Ltd. Medical DistributorsDistribution Services Part of United Therapeutics Corp., United Therapeutics Europe Ltd. is a wholesaler of pharmaceutical goods. The company is based in Duxford, UK. | Director/Board Member | 2016-08-22 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
United Therapeutics Europe Ltd.
United Therapeutics Europe Ltd. Medical DistributorsDistribution Services Part of United Therapeutics Corp., United Therapeutics Europe Ltd. is a wholesaler of pharmaceutical goods. The company is based in Duxford, UK. | Distribution Services |
Miromatrix Medical, Inc.
 Miromatrix Medical, Inc. BiotechnologyHealth Technology Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN. | Health Technology |
- Stock Market
- Insiders
- Michael Benkowitz
